These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states. Olajide D; Lader M J Clin Psychopharmacol; 1987 Jun; 7(3):148-52. PubMed ID: 2885344 [TBL] [Abstract][Full Text] [Related]
8. Drug interactions in controlled clinical trials. Gershon S J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):95-9. PubMed ID: 6130080 [TBL] [Abstract][Full Text] [Related]
9. Review of the side-effect profile of buspirone. Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641 [TBL] [Abstract][Full Text] [Related]
10. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial. Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006 [TBL] [Abstract][Full Text] [Related]
11. Impact of anxiety therapy on patients' quality of life. Feighner JP Am J Med; 1987 May; 82(5A):14-9. PubMed ID: 2884872 [TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. Feighner JP; Merideth CH; Hendrickson GA J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):103-8. PubMed ID: 6130066 [TBL] [Abstract][Full Text] [Related]
14. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats. Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217 [TBL] [Abstract][Full Text] [Related]
15. The side effect profile of buspirone in comparison to active controls and placebo. Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065 [TBL] [Abstract][Full Text] [Related]
16. Comparison of buspirone and diazepam in generalized anxiety disorder. Jacobson AF; Dominguez RA; Goldstein BJ; Steinbook RM Pharmacotherapy; 1985; 5(5):290-6. PubMed ID: 2866493 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a putative anxiolytic agent: ipsapirone. Borison RL; Albrecht JW; Diamond BI Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371 [TBL] [Abstract][Full Text] [Related]
18. Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy. Goldberg HL Pharmacotherapy; 1984; 4(6):315-24. PubMed ID: 6151170 [TBL] [Abstract][Full Text] [Related]
19. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Bencan Z; Sledge D; Levin ED Pharmacol Biochem Behav; 2009 Nov; 94(1):75-80. PubMed ID: 19643124 [TBL] [Abstract][Full Text] [Related]
20. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Goa KL; Ward A Drugs; 1986 Aug; 32(2):114-29. PubMed ID: 2874976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]